Amgen (AMGN) Net Income (2009 - 2026)

Amgen (AMGN) has reported Net Income for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income rose 5.14% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $7.8 billion (up 31.47% YoY), while the FY2025 annual figure was $7.7 billion, up 88.53% from the prior year.
• Net Income came in at $1.8 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
• The five-year high for Net Income was $3.2 billion in Q3 2025, with the low at -$113.0 million in Q1 2024.
• Average Net Income over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2022.
• Across the five-year window, Net Income sank 103.98% in 2024 and surged 1630.97% in 2025, its largest moves.
• Year by year, Net Income stood at $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then soared by 112.6% to $1.3 billion in 2025, then surged by 36.46% to $1.8 billion in 2026.
• According to Business Quant data, Net Income over the past three periods registered $1.8 billion, $1.3 billion, and $3.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.